Priming of Qualitatively Superior Human Effector CD8+ T Cells Using TLR8 Ligand Combined with FLT3 Ligand.
J Immunol
; 196(1): 256-263, 2016 Jan 01.
Article
in En
| MEDLINE
| ID: mdl-26608912
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphocyte Activation
/
T-Lymphocytes, Cytotoxic
/
Immunotherapy, Adoptive
/
Toll-Like Receptor 8
/
Membrane Proteins
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Immunol
Year:
2016
Document type:
Article
Affiliation country:
France